EGFR tyrosine kinase inhibitors in squamous cell lung cancer.

Lancet Oncology

PubMedID: 26156654

Hirsch FR, Herbst RS, Gandara DR. EGFR tyrosine kinase inhibitors in squamous cell lung cancer. Lancet Oncol. 2015;16(8):872-3.
An abstract is not available. Please access the article through the links below.